StockNews.com Downgrades Iradimed (NASDAQ:IRMD) to Buy
Iradimed (NASDAQ:IRMD – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday. Iradimed Price Performance NASDAQ:IRMD opened at $60.48 on Thursday. The firm has a 50-day moving average of $57.16 and a two-hundred day moving average of $52.02. The stock […]
Iradimed (NASDAQ:IRMD – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday. Iradimed Price Performance NASDAQ:IRMD opened at $60.48 on Thursday. The firm has a 50-day moving average of $57.16 and a two-hundred day moving average of $52.02. The stock […]
